Cellular Immunotherapies for Multiple Myeloma: Current Status, Challenges, and Future Directions
ZL Yan, YW Wang, YJ Chang - Oncology and Therapy, 2022 - Springer
Multiple myeloma (MM) remains incurable due to relapse, although the use of proteasome
inhibitors, immunomodulatory drugs, CD38-targeting antibodies, and autologous stem cell …
inhibitors, immunomodulatory drugs, CD38-targeting antibodies, and autologous stem cell …